Anzai, T.; Saijou, S.; Takashima, H.; Hara, M.; Hanaoka, S.; Matsumura, Y.; Yasunaga, M.
Identification of CD73 as the Antigen of an Antigen-Unknown Monoclonal Antibody Established by Exosome Immunization, and Its Antibody–Drug Conjugate Exerts an Antitumor Effect on Glioblastoma Cell Lines. Pharmaceuticals 2022, 15, 837.
https://doi.org/10.3390/ph15070837
AMA Style
Anzai T, Saijou S, Takashima H, Hara M, Hanaoka S, Matsumura Y, Yasunaga M.
Identification of CD73 as the Antigen of an Antigen-Unknown Monoclonal Antibody Established by Exosome Immunization, and Its Antibody–Drug Conjugate Exerts an Antitumor Effect on Glioblastoma Cell Lines. Pharmaceuticals. 2022; 15(7):837.
https://doi.org/10.3390/ph15070837
Chicago/Turabian Style
Anzai, Takahiro, Shinji Saijou, Hiroki Takashima, Misato Hara, Shingo Hanaoka, Yasuhiro Matsumura, and Masahiro Yasunaga.
2022. "Identification of CD73 as the Antigen of an Antigen-Unknown Monoclonal Antibody Established by Exosome Immunization, and Its Antibody–Drug Conjugate Exerts an Antitumor Effect on Glioblastoma Cell Lines" Pharmaceuticals 15, no. 7: 837.
https://doi.org/10.3390/ph15070837
APA Style
Anzai, T., Saijou, S., Takashima, H., Hara, M., Hanaoka, S., Matsumura, Y., & Yasunaga, M.
(2022). Identification of CD73 as the Antigen of an Antigen-Unknown Monoclonal Antibody Established by Exosome Immunization, and Its Antibody–Drug Conjugate Exerts an Antitumor Effect on Glioblastoma Cell Lines. Pharmaceuticals, 15(7), 837.
https://doi.org/10.3390/ph15070837
